Attention-Deficit/Hyperactivity Disorder (ADHD) Protocol

Neurological HealthModerate Evidence
7
supplements
2
Primary
5
Supporting
0
Grade A
75
Studies

Primary Stack

Core supplements with strongest evidence
1-2g EPA+DHA daily (higher EPA ratio)

Essential for brain structure and function; EPA and DHA support neurotransmitter activity and reduce neuroinflammation

ADHD SymptomsAttentionWorking Memory
25 studies2,000 participants
15-30mg daily

Essential for dopamine regulation; deficiency common in ADHD; may enhance medication response

ADHD Symptoms
12 studies600 participants

Supporting Stack

Additional supplements for enhanced results
As needed based on ferritin levels (target ferritin >30-50 ng/mL)

Required for dopamine synthesis; low ferritin associated with worse ADHD symptoms

10 studies500 participants
200-400mg daily

Calming effect on nervous system; deficiency common in ADHD; supports neurotransmitter function

ADHD Symptoms
8 studies400 participants
100-200mg daily

Supports neuronal membrane function and neurotransmitter activity; may improve attention and memory

ADHD SymptomsAttentionHyperactivityImpulsivity
6 studies300 participants

Supports brain energy metabolism and acetylcholine production; may improve attention

ADHD SymptomsAggressionAttention
6 studies300 participants
1000-2000 IU daily (based on blood levels)

Deficiency associated with ADHD; vitamin D receptors in brain areas involved in attention

8 studies500 participants

How This Protocol Works

Simple Explanation

ADHD is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. It affects brain regions involved in executive function and uses dopamine and norepinephrine as key neurotransmitters. While stimulant medications are the most effective treatment, certain nutritional deficiencies are more common in ADHD and addressing them may help reduce symptoms.

IMPORTANT: These supplements are meant to complement, not replace, evidence-based ADHD treatment. Stimulant and non-stimulant medications remain the most effective treatments. Always work with your healthcare provider.

Omega-3 Fatty Acids are essential components of brain cell membranes and are crucial for neurotransmitter signaling. Children with ADHD often have lower blood levels of omega-3s. Multiple meta-analyses show that omega-3 supplementation (especially with higher EPA) can modestly improve ADHD symptoms, particularly inattention. The effect size is smaller than medication but may be additive.
Zinc is essential for dopamine regulation—the key neurotransmitter affected in ADHD. Many children with ADHD have low zinc levels, and supplementation may improve symptoms, particularly when combined with stimulant medication. Some studies show zinc enhances the effectiveness of stimulant medications.
Iron is required for dopamine synthesis. Low ferritin levels (iron stores) are significantly more common in children with ADHD and correlate with symptom severity. If ferritin is low (below 30-50 ng/mL), iron supplementation may improve symptoms. Always test before supplementing.
Magnesium has calming effects on the nervous system and is involved in over 300 enzymatic reactions including those affecting neurotransmitters. Magnesium deficiency is common in ADHD, and supplementation (often combined with vitamin B6) may help reduce hyperactivity and improve attention.
Phosphatidylserine is a phospholipid that supports neuronal membrane function. Studies in children with ADHD show improvements in attention, impulsivity, and short-term memory, though more research is needed.
L-Carnitine/Acetyl-L-Carnitine supports brain energy metabolism and may enhance acetylcholine production. Acetyl-L-carnitine crosses the blood-brain barrier more easily. Studies show modest improvements in attention and behavior.
Vitamin D deficiency is more common in children with ADHD. Vitamin D receptors are found in brain areas involved in attention and executive function. While evidence is still emerging, correcting deficiency may be helpful.

Expected timeline: Omega-3s: 8-12 weeks. Zinc/Iron (if deficient): 4-8 weeks. Magnesium: 2-4 weeks. Best approach is to test for deficiencies and correct them while continuing evidence-based treatments.

Clinical Perspective

ADHD is characterized by developmentally inappropriate levels of inattention, hyperactivity, and impulsivity. Neurobiologically, it involves prefrontal cortex hypofunction, altered dopaminergic and noradrenergic neurotransmission, and structural/functional brain differences. First-line treatments are stimulant medications (methylphenidate, amphetamines) with response rates of 70-80%. This protocol addresses nutritional factors that may modulate neurotransmitter function and brain development.

CRITICAL: Supplements are adjunctive to behavioral therapy and medication. Screen for nutritional deficiencies (iron, zinc, omega-3 index) before supplementation. Monitor for interactions with ADHD medications.

Omega-3 Fatty Acids (B-grade): DHA is major structural component of neuronal membranes; EPA modulates inflammation and prostaglandin synthesis. Lower RBC omega-3 levels documented in ADHD. Meta-analysis (16 RCTs): modest improvement in ADHD symptoms, effect size 0.26 for inattention (PMID: 29683187). Higher EPA:DHA ratio may be more effective. Systematic review supports benefit (PMID: 26360172). 1-2g EPA+DHA daily; look for high-EPA formulas.
Zinc (B-grade): Cofactor for delta-aminolevulinic acid dehydratase (rate-limiting in dopamine synthesis), modulates dopamine transporter. Lower serum zinc in ADHD. Meta-analysis: zinc supplementation improves hyperactivity and impulsivity symptoms (PMID: 28040871). May enhance stimulant efficacy. 15-30mg/day; monitor for copper depletion with prolonged use.
Iron (B-grade): Essential for tyrosine hydroxylase (dopamine synthesis) and brain development. Systematic review: lower ferritin in ADHD; ferritin <30 ng/mL associated with worse symptoms (PMID: 28009986). Test ferritin before supplementing. Target ferritin >30-50 ng/mL. Dose based on deficiency severity; typically 3-6 mg/kg/day in children.
Magnesium (B-grade): NMDA receptor modulator, reduces glutamatergic excitotoxicity, involved in catecholamine synthesis. Deficiency common in ADHD. RCT: magnesium + vitamin B6 improved hyperactivity, attention, and aggression (PMID: 26978056). 200-400mg/day; often combined with B6. Glycinate form well-tolerated.
Phosphatidylserine (C-grade): Major phospholipid of inner neuronal membrane leaflet. Supports membrane fluidity, receptor function, and neurotransmitter release. Pilot study: 200mg/day improved auditory memory and inattention in children with ADHD (PMID: 22682676). 100-200mg/day. Often combined with omega-3s.
L-Carnitine/Acetyl-L-Carnitine (ALCAR) (B-grade): ALCAR crosses BBB, provides acetyl groups for acetylcholine synthesis, supports mitochondrial function. RCT: ALCAR improved attention and reduced aggression in ADHD boys (PMID: 18510674). 500-2000mg/day. ALCAR preferred for cognitive effects.
Vitamin D (C-grade): VDR in prefrontal cortex, hippocampus. Deficiency more common in ADHD. Systematic review: correlation between low vitamin D and ADHD; supplementation studies emerging (PMID: 29061431). 1000-2000 IU/day; target 25(OH)D >40 ng/mL.

Biomarker targets: Ferritin (>30-50 ng/mL), serum zinc, 25(OH)D (>30 ng/mL), RBC omega-3 index (>8%), ADHD rating scales (Conners, SNAP-IV), academic performance metrics.

Protocol notes: Behavioral therapy (parent training, organizational skills training) is evidence-based. Stimulant medications (methylphenidate, amphetamines) remain most effective treatment. Non-stimulants (atomoxetine, guanfacine, viloxazine) are alternatives. Elimination diets (few foods diet) help subset of children—consider if family history of food sensitivity. Artificial food colors may worsen symptoms in some. Regular exercise improves executive function. Adequate sleep critical—address sleep disorders. Screen for comorbidities (anxiety, depression, learning disorders). Avoid marketing hype around 'natural ADHD cures'—most lack evidence. Mediterranean-style diet pattern associated with lower ADHD risk.